RING domains of E3 ligases promote transfer of Ub (ubiquitin) from the E2∼Ub conjugate to target proteins. In many cases interaction of the E2∼Ub conjugate with the RING domain requires its prior dimerization. Using cross-linking experiments we show that E2 conjugated ubiquitin contacts the RING homodimer interface of the IAP (inhibitor of apoptosis) proteins, XIAP (X-linked IAP) and cIAP (cellular IAP) 2. Structural and biochemical analysis of the XIAP RING dimer shows that an aromatic residue at the dimer interface is required for E2∼Ub binding and Ub transfer. Mutation of the aromatic residue abolishes Ub transfer, but not interaction with Ub. This indicates that nuleophilic attack on the thioester bond depends on precise contacts between Ub and the RING domain. RING dimerization is a critical activating step for the cIAP proteins; however, our analysis shows that the RING domain of XIAP forms a stable dimer and its E3 ligase activity does not require an activation step.
INTRODUCTION
Modification of proteins with Ub (ubiquitin; ubiquitylation) has a central role in regulating protein abundance and is widely recognized as a key signal that modulates protein-protein interactions. A three-step enzymatic cascade brings about the attachment of Ub to target proteins. Ub E3 ligases, which are required for the last step, have a critical role as they specify the substrate to be ubiquitylated and recruit the Ub-conjugating enzyme (E2) as a thioester Ub (E2∼Ub) conjugate. Most E3 ligases belong to the RING family, and are characterized by the presence of conserved cysteine and histidine residues that coordinate two structural zinc ions [1] . Upon association of the RING domain with the E2∼Ub conjugate, the thioester bond becomes susceptible to nucleophilic attack by the amine group of the target lysine residue, and an isopeptide bond between the lysine side chain and the C-terminus of Ub results.
Interaction of the RING domain with E2 proteins has been widely studied, and the E2-binding site on the RING domain can be readily identified [2] . However, these studies have not revealed how the RING domain promotes Ub transfer because association of E2 with the RING domain does not prompt significant structural changes in E2 [3] [4] [5] . In addition, active and inactive complexes appear similar [6, 7] . A caveat of these studies is that they have focused on the RING-E2 complex and not the RING-E2∼Ub conjugate complex required for Ub transfer. Accumulating evidence indicates that it is not just the interaction of the E2 with the RING domain that is important for Ub transfer, but that the Ub moiety of the conjugate also contacts the RING domain [8] [9] [10] . The extent of the interaction between Ub and the RING domain has been revealed recently [11, 12] , and these elegant studies provide a molecular explanation for how the RING domain primes the E2∼Ub conjugate for catalysis.
Over 600 RING domains are encoded in the human genome [1] . Although many RING domains can promote Ub transfer as a monomer, in a number of well-studied E3s, RING dimerization is important for activity [2] . Not only did the structures of RNF (RING finger protein) 4 and ML-IAP [melanoma IAP (inhibitor of apoptosis)] in complex with the E2∼Ub conjugate reveal the interaction site for Ub on the RING domain [11, 12] , but they also showed that while the E2 binds to one RING, Ub contacts the RING dimer interface. The RING domains of RNF4 and ML-IAP, as well as other members of the IAP family of proteins, are flanked on the C-terminal side by a conserved amino acid sequence [13] . The conserved residues comprise part of the dimer interface and contact Ub, and this explains why RING dimerization is essential for Ub transfer by these E3s.
IAPs are distinguished by the presence of at least one BIR (baculoviral IAP repeat) domain and a RING domain (Supplementary Figure S1A at http://www.biochemj.org/bj/450/ bj4500629add.htm), and they can promote either the ubiquitylation of substrate proteins or their own autoubiquitylation [13] . Dimerization of the RING domain of the cIAP (cellular IAP) proteins, cIAP1 and cIAP2, plays a critical role in regulating Ub transfer [14, 15] . In the absence of a stimulus, the RING domain of cIAP1 is sequestered by BIR3, a UBA (Ub-associated) domain and a CARD (caspase recruitment domain), such that it is predominantly monomeric and unable to interact with the E2∼Ub conjugate in a productive manner. The BIR3 domain contains a pocket that has been the focus of drug discovery initiatives [16, 17] , and small-molecule compounds, referred to as SMAC (second modulator of apoptotic proteases) mimetics, that bind to the BIR3 domains of cIAP1 and prompt a conformational change that frees the RING domain, allowing RING-mediated dimerization [14, 15] . Dimerization of the RING domain confers E3 ligase activity on cIAP1, and its autoubiquitylation and degradation ensues [18, 19] . Loss of cIAPs limits prosurvival signalling and cell death occurs.
The cIAP1-directed SMAC mimetic compounds have entered clinical trials for the treatment of cancer [20] . However, they lack selectivity and target the BIR domains of other IAPs as well, and the monovalent and bivalent compounds can elicit distinct effects [21] . Importantly, XIAP [X-linked IAP; also known as BIRC4 (BIR-containing 4)], which binds to and is a potent inhibitor of caspase enzymes [22] and is often over-expressed in tumours, is also a target of these compounds. Recent reports suggest that XIAP has an essential role in NOD2 (nucleotide-binding and oligomerization domain 2) signalling because it mediates ubiquitylation of RIPK2 (receptor-interacting serine-threonine kinase 2) and patients with mutations in XIAP have impaired NOD2 signalling [23] . XIAP can also ubiquitylate and control the abundance of Rac1, with down-regulation of XIAP associated with increased Rac1 levels and cell migration [24] . Understanding the molecular basis of XIAP E3 ligase activity is therefore critical because its inactivation might have unexpected consequences.
In the present study, we characterized the molecular mechanisms that regulate Ub transfer by XIAP. The results of the present study show that the XIAP RING dimer is stable and, unlike cIAP1, the E3 ligase activity is not subject to autoinhibition by the BIR3 and UBA domains. Furthermore, we utilize cross-linking approaches to show that the conserved Cterminal tail of XIAP interacts with Ub and is required to prime the E2∼Ub thioester bond for catalysis. The present study shows that cross-linking approaches may be generally applicable for the identification of Ub-binding sites. Importantly, in combination with recent structural data, our in-solution studies show that precise interactions between the RING and Ub are required to prompt nucleophilic attack and Ub transfer.
EXPERIMENTAL

Constructs and mutagenesis
XIAP (NCBI accession number NM_001167) constructs (Supplementary Figure S1A ) and UBE2D2 (Ub-conjugating enzyme E2 D2) were cloned into the pGex-6p3 vector. The purified proteins had five additional residues, GPLGS, at their N-terminus. The cDNA encoding human Ub was cloned into the pET3a vector and expressed without a tag. The one-step site-directed mutagenesis protocol was adapted to introduce mutations [25] .
Protein expression and purification
All GST (glutathione transferase)-fused proteins were expressed in Escherichia coli BL21(DE3) cells at 18
• C overnight in LB (Luria-Bertani) medium. Protein expression was induced by addition of IPTG (isopropyl β-D-thiogalactopyranoside; 0.2 mM final concentration). Cells were harvested, sonicated (six times for 30 s at 30 % amplitude) in PBS buffer (pH 7.4) and the soluble protein was bound to glutathione-Sepharose. After binding, the resin was thoroughly washed three times with 10× vol. PBS buffer and the GST tag was removed by the addition of 3C protease (GE Healthcare) at 4
• C overnight. Proteins were purified using either a Superdex 75 or 200 column (GE Healthcare) equilibrated in PBS. Ub was expressed and purified as described previously [26] .
Production of the E2∼Ub conjugate
An E2∼Ub
oxy (oxyester UBE2D2∼Ub conjugate) was prepared as described previously [14] . To prepare E2∼Ub SS (disulfide-linked UBE2D2∼Ub conjugate), all of the cysteine residues in UBE2D2, except for Cys 85 , were mutated to serine and the S22R mutation was introduced to eliminate non-covalent interactions with Ub. Purified UBE2D2 was used to prepare a conjugate as described previously [27, 28] . The reaction was generally completed within 2-3 days. The E2∼Ub SS conjugate was separated from the reaction mix using a Superdex 75 equilibrated in 50 mM sodium phosphate buffer (pH 6.0) containing 50 mM NaCl.
Protein crystallization and structure solution
Crystals of the X-RING [RING domain (residues 429-497) from XIAP; both the WT (wild-type) and F495L mutant] were grown using the vapour-diffusion method at 18
• C. 
Binding experiments
ITC (isothermal titration calorimetry) experiments were performed using a VP-ITC (GE Healthcare) at 25
• C. Samples were dialysed into PBS buffer overnight at 4
• C. UBE2D2 (413 μM) was injected (1 × 5 μl and 27 × 10 μl) into 43 μM XIAP RING. The data was analysed using Origin 7 software and fit to a single site-binding model. SPR (surface plasmon resonance) was carried out using a Biacore X100 (GE Healthcare) at 25
• C and a flow rate of 30 μl/min. The running buffer was PBS (pH 7.4) containing 0.1 % Tween 20. Approximately 13000 RU (response units) of anti-GST antibody was immobilized on to the CM5 chip according to the manufacturer's instructions (GE Healthcare). Approximately 1000 RU of purified GST and GST-fused UBE2D2 were captured in each Fc (flow cell). The signal from Fc1 (the reference cell) was subtracted from all data. A total of 15 μl of analyte was injected for the binding experiments. Glycine (40 μl of 10 mM, pH 2.2) was twice injected for regeneration of the chip. Capturing ∼1000 RU of GST-fused UBE2D2 resulted in generating ∼50 RU when 17 μM of X-RING were injected. To calculate the K d value, Prism (version 5) software (GraphPad Software) and a one site (total) binding model were employed. For the competition assay, a 1:1 ratio of X-RING and either the E2∼Ub SS conjugate or UBE2D2, were mixed on ice for at least 30 min prior to injection. Experiments were performed in triplicate.
Discharge and autoubiquitylation assays
The oxyester conjugate was used for the discharge assays. Conditions were as described previously [14] except the final concentrations of X-RING and the oxyester E2∼Ub oxy were 8 and 20 μM respectively. Autoubiquitylation reactions containing 100 μM Ub, 5.8 μM UBE2D2, 100 nM E1 and 4 μM X-BUR (XIAP BIR3, UBA and RING domains) in 20 mM Tris/HCl (pH 7.5), 50 mM NaCl, 5 mM ATP, 2 mM MgCl 2 and 2 mM DTT (dithiothreitol) were incubated at 37
• C. Following the addition of SDS/PAGE sample buffer, samples were separated by either SDS/PAGE (14.5 % gels) or 4-12 % NuPAGE BisTris gels (LifeScience). 
SEC (size-exclusion chromatography) and MALLS (multiple-angle laser-light scattering) analysis
For molecular mass analysis, MALLS coupled with either a Superdex 75 or a 200 HR 10/30 column was employed as described previously [14] . For analytical SEC, UBE2D2 was mixed with X-RING at a final concentration of 50 and 200 μM respectively, and left on ice for 30 min. Mixed samples were separated on a Superdex 75 HR 10/30 column equilibrated with PBS. The isolated and purified proteins were also analysed under identical conditions. Fractions (500 μl) were collected and analysed by SDS/PAGE.
X-RING-E2∼Ub
SS conjugate cross-linking and MS
Cross-linking was performed using 7 or 15 μM X-RING, 15 μM E2∼Ub SS conjugate and 250 μM BS 3 [bis(sulfosuccinimidyl) suberate; Sigma] cross-linker in 20 μl of PBS buffer. Samples were incubated at room temperature (20 • C) for 30 min, followed by the addition of 1 μl of 1 M Tris/HCl buffer (pH 7.5) to stop the reaction (on ice for 15 min). SDS/PAGE sample buffer (5 μl) was added and half of the sample was analysed by SDS/PAGE (16 % gel). The bands of interest were excised, digested with trypsin and analysed by LC (liquid chromatography)-coupled LTQ Orbitrap MS (Thermo Scientific) as outlined in the Supplementary Online data.
Identification of the specific RING-Ub cross-linkage
To identify cross-linked peptides the raw data were analysed using both the Xcalibur software (Thermo Scientific), to search for predicted cross-linked peptide masses, and a database approach for cross-linked peptides [29] . See the Supplementary Online data.
RESULTS
The RING domain of XIAP forms a stable dimer that is not subject to autoinhibition
The structure of the RING domain (residues 429-497) from XIAP (X-RING) was determined at 2.2 Å (1 Å = 0.1 nm; Figure 1A and Supplementary Figure S2A at http://www.biochemj.org/bj/450/ bj4500629add.htm). The XIAP RING dimer is very similar to the cIAP2 RING dimer, with dimerization mediated by the core RING domain as well as the N-terminal helix and the Cterminal β-strand ( Figure 1A and Supplementary Figures S2B and S2C). The dimer interface comprises an extended hydrophobic region that is surrounded by a network of hydrogen bonds and dimerization buries ∼ 900 Å 2 surface area per monomer (Supplementary Figure S2A) . The asymmetric unit contains a RING dimer, with the C-terminal tail residues adopting two conformations (Supplementary Figure S2D) . In one RING domain, crystal contacts are present and all of the tail residues are resolved, although the side chain of Phe 495 adopts two distinct conformations (Supplementary Figure S2E) . For the other protomer, the tail residues do not make crystal contacts and the side chain of Phe 495 is packed against His 467 , a zinc-co-ordinating residue. The tail of this monomer is used in the structural Figures. This conformational heterogeneity suggests that the C-terminal tail is flexible.
The isolated RING domain (at a concentration of 25 μM) forms a stable dimer in solution and MALLS coupled in-line to SEC gave a calculated mass of 15.9 kDa, close to the theoretical mass for the RING dimer (16.8 kDa) ( Figure 1B) . However, to our surprise, a longer protein (monomer mass of 29.6 kDa), which comprises the BIR3, UBA and RING domains (X-BUR) (Supplementary Figure S1A ) also eluted as a stable dimer, with an observed mass of 52.8 kDa ( Figure 1B) . In comparable conditions, and at much higher concentrations, the equivalent cIAP constructs are largely monomeric [14] . To discount the possibility that X-BUR dimerization depends on contacts outside of the RING domain, we mutated Val 461 , located at the RING dimer interface, to a glutamic acid residue (V461E) and evaluated the oligomeric state. Both the V461E mutant X-RING and X-BUR proteins behaved as monomers, indicating that RING dimerization is required for X-BUR dimerization (Figure 1B The contribution of RING dimerization to Ub transfer by XIAP was then investigated. Although the isolated RING itself can promote its autoubiquitylation (Supplementary Figure S3B) , we used X-BUR for the present study as it is more readily autoubiquitylated. In contrast, monomeric V461E X-BUR does not promote the formation of Ub ladders on itself ( Figure 1C ). This indicates that, like cIAP1 and cIAP2, RING dimerization is required for Ub transfer by XIAP. Next, we investigated the effect of adding monovalent and bivalent SMAC mimetic compounds that bind to the BIR3 domain. For cIAP1 and cIAP2, these compounds disrupt the monomeric auto-inhibited state and result in RING dimerization that is associated with increased Ub transfer [14] . For XIAP, because the RING domain is already dimeric, we predicted that the compounds would not effectively enhance Ub transfer. Indeed, comparable X-BUR autoubiquitylation was observed in the absence of any compounds, or in the presence of a monovalent (Comp. C), bivalent (Comp. A) or inactive enantiomer (Comp. B) SMAC mimetic compounds ( Figure 1D ). This suggests that the BIR3 and UBA domains of XIAP do not inhibit RING dimerization and, as a consequence, compounds that bind to BIR3 of XIAP do not enhance Ub transfer by XIAP in vitro.
Dimerization and Phe 495 are required for Ub transfer by XIAP RING
A number of studies have indicated that the conserved C-terminal aromatic residue, Phe 495 in the case of XIAP (Supplementary Figure S1B) , has an important role in promoting Ub transfer because mutation of this residue attenuates RING E3 ligase activity [3, 8, 14] . In the recently reported RNF4-and ML-IAPE2∼Ub complex structures the equivalent aromatic residues packs against Gly 35 at the base of the α-helix in Ub [12] . However, the role of the aromatic residue remains somewhat uncertain as many of the mutants that have been studied in cIAP1, cIAP2 and RNF4 disrupted RING dimerization, and not surprisingly Ub transfer was abolished. In contrast, mutation of the phenylalanine residue to alanine in XIAP (F495A) did not disrupt RING dimerization of either X-RING or X-BUR (Figure 2A and Supplementary Figure  S3A ), yet Ub transfer was abrogated ( Figure 2B) .
To understand the contribution of Phe 495 to Ub transfer, in addition to the alanine residue mutant (F495A), we introduced the aromatic residues tyrosine and tryptophan (F495Y and F495W respectively) as well as the hydrophobic residue leucine (F495L). All mutants formed stable dimers (Figure 2A ) and autoubiquitylation assays showed that Phe 495 could be replaced by tyrosine and tryptophan, but not by leucine ( Figure 2B) . Similarly, using Ub-discharge assays, where the ability of the RING dimer to promote the disappearance of an oxyester-linked UBE2D2∼Ub conjugate (E2∼Ub oxy ) was measured, F495Y was comparable with the wild-type, whereas F495L was equivalent to the inactive monomeric V461E (Figure 2C ). Ub transfer therefore depends on an aromatic side chain at position 495, and substitution by the hydrophobic side chain of leucine inactivates XIAP. To confirm that introduction of the leucine had not altered the conformation of the RING dimer, we solved the structure of F495L X-RING. The structure of the F495L X-RING dimer overlaid closely with the wild-type protein (Supplementary Figure S2F) and only small differences near the site of the mutation were apparent ( Figure 2D ).
Together these experiments show that in XIAP the aromatic residue in the tail is not required for RING dimerization, but is essential for Ub transfer. Because neither the dimeric F495L nor monomeric V461E forms of X-RING could promote the discharge of Ub from E2∼Ub oxy , this suggests that both a RING dimer and the aromatic residue are required to activate the E2∼Ub conjugate.
RING dimerization is required for the interaction of XIAP RING with E2 and E2∼Ub
To investigate the role of RING dimerization in Ub transfer, we characterized the ability of X-RING to bind the E2, UBE2D2. Using ITC the interaction between X-RING and UBE2D2 was shown to have a K d value of 30 μM, whereas a K d value of 42 μM was obtained using SPR ( Figures 3A and 3B) . These values are in good agreement and are similar to the 20-40 μM interaction measured for cIAP2 RING binding to UBE2D2 [3] . We next used SPR to evaluate the ability of the mutant X-RING proteins to bind to GST-tagged UBE2D2 immobilized using an anti-GST chip. Consistent with the structural data, the F495L mutation did not disrupt interaction with the E2 (Figure 3C ). In contrast, binding between UBE2D2 and the monomeric protein, V461E, was significantly reduced. Notably, even at high concentrations (50 μM), only a minimal response was obtained, suggesting that the affinity was very low.
The weak interaction between UBE2D2 and monomeric X-RING was also apparent when samples were analysed by SEC. For X-RING, prior mixing with UBE2D2 results in earlier elution from the column ( Figure 3D ). In contrast, no shift in the elution volume or protein-containing fractions was observed when UBE2D2 was mixed with the monomeric V461E X-RING. Dimerization of X-RING is therefore required for interaction with the E2 even though the RING dimer interface is distant from the E2-binding site. This suggests that in the monomeric form either the E2-binding site on the RING is masked as in the cIAP1 monomer [15] or that the E2-binding site is not complete.
Ub contacts the C-terminal tail of the XIAP RING domain
In the recently described structures of the RNF4 and ML-IAP RING dimers bound to E2∼Ub, Ub contacts the dimer interface that includes the C-terminal tail of one RING domain, whereas .0744) shows y-ion fragmentations from the C-termini of both peptides (indicated by arrows pointing to the right-hand side in the above sequence schematic diagram) and a further y-ion series of a cross-link-containing fragment in the high mass region of the spectrum (arrows pointing to the left-hand side) clearly confirming the cross-link between both peptides. Q*, pyroglutamic acid formed from glutamine at the free N-terminus after tryptic cleavage; M*, oxidised methionine.
E2 binds the canonical interface on the other RING domain [11] . Our earlier modelling studies, where we superimposed the XIAP RING dimer structure and the 'closed' UBE2K∼Ub structure [30] on to the cIAP2 RING-E2 complex structure [3] , suggested the RING domain of XIAP might make similar contacts (Supplementary Figure S4A at http://www.biochemj.org/bj/450/ bj4500629add.htm). Autoubiquitylation assays supported this model because both the F495L mutant and an E2 interface mutant (I452A/D455A), which cannot interact with the E2, were inactive alone. However, when the two mutants were mixed prior to the assay, significant autoubiquitylation was observed (Figure 4A ), suggesting that RING heterodimers form and that the E2-binding site on one RING and the C-terminal tail of the interacting RING together are sufficient to confer E3 ligase activity. This model predicts that X-RING would have greater affinity for E2∼Ub compared with E2 alone. A competitive pull-down assay that assessed the ability of immobilized GST-RING to bind to UBE2D2 and disulfide-linked UBE2D2∼Ub conjugate (E2∼Ub SS ) supported this conclusion ( Figure 4B) . Comparison of the band intensity when equimolar amounts of E2 and E2∼Ub SS were incubated with the RING suggests that the affinity of E2∼Ub for the RING is ∼ 1.5-2-fold greater than the E2 alone ( Figure 4B, lane 5) .
To directly evaluate our model, we employed cross-linking experiments. Ub has seven surface lysine residues [31] and the RING domain of XIAP has a lysine at position 493 in the Cterminal tail, making analysis of their interaction well-suited for cross-linking studies with BS 3 , a cross-linker with an 11 Å spacer arm that reacts with primary amine groups. Incubation of purified X-RING and E2∼Ub SS with BS 3 resulted in the appearance of several higher molecular mass bands on a PAGE gel ( Figure 4C ). Digestion and analysis of these bands by LC-coupled tandem MS identified the major cross-linked species as that derived from cross-linking between Lys 33 of Ub and Lys 493 of XIAP ( Figures 4D  and 4E ). No other cross-linked ubiquitin-RING species were identified and this cross-link was not observed for monomeric V461E X-RING (results not shown). This suggests that Lys 33 of Ub is within 11 Å of Lys 493 in XIAP when the RING dimer binds to the E2∼Ub conjugate, and the absence of other cross-links suggests that this conformation is prevalent in solution.
We also showed that a similar contact is made between the RING domain of cIAP2 and Ub. The C-terminal tail of cIAP2 has an arginine residue (Arg 600 ) at the equivalent position to Lys 493 of XIAP and, accordingly, the cross-linked species are of reduced intensity ( Figure 4C ). However, replacement of the arginine residue with lysine (R600K) resulted in more intense bands upon cross-linking, and analysis by MS identified a fragment due to cross-linking of Lys 600 of R600K cIAP2 with Lys 33 of Ub ( Supplementary Figures S4B and S4C ). Again, crosslinking is diminished for the monomeric protein (V568E mutant) containing the R600K mutation and no cross-linked peptides were detected. Together, these results show that Ub interacts with the C-terminal tail at the dimer interface of XIAP and the cIAP2 RING homodimer. These findings are consistent with the recently determined structures of the RNF4 and ML-IAP RING domains in complex with the E2∼Ub conjugate [12] and demonstrate the utility of cross-linking studies, coupled with MS, to elucidate novel Ub-binding sites.
Specific contacts between the E2∼Ub conjugate and RING dimer are required for activity
To further dissect the role of Phe 495 in XIAP, we also carried out cross-linking experiments with the active F495Y and inactive F495L mutants of X-RING. To our surprise, even the inactive X-RING dimer that contained the F495L mutation was efficiently cross-linked to the E2∼Ub conjugate ( Figure 5A ) although the intensity of the band appeared to be slightly reduced, MS identified the fragment that corresponded to cross-linking of Lys 33 in Ub to Lys 493 in the RING domain ( Supplementary Figures S5A  and S5B ). This suggests that even though the F495L mutation attenuated Ub discharge and transfer ( Figures 2B and 2C) , it does not abolish interaction with Ub.
Next, we measured the ability of the UBE2D2∼Ub conjugate to bind to each X-RING protein using SPR. For these experiments, we used the disulfide-linked conjugate (E2∼Ub SS ) that is not subject to Ub discharge together with a competitive binding assay as illustrated in Figure 5 (B). For each RING, we measured binding to immobilized UBE2D2 in the absence and presence of either the E2∼Ub SS or UBE2D2. As shown previously, the WT, F495L and F495Y proteins had similar affinities for the E2 and prior mixing with purified E2 resulted in comparable binding for each RING protein ( Figure 5C ). In contrast, prior addition of the E2∼Ub SS conjugate to the RING dimers reduced binding of the WT and F495Y proteins to immobilized UBE2D2, whereas a more modest reduction was seen for F495L X-RING. However, the reduction was considerably greater than when UBE2D2 was used as the competitor, indicating that the F495L mutant still preferentially bound to the E2∼Ub conjugate.
Together, these results suggest that mutation of phenylalanine to leucine in the XIAP RING domain weakens, but does not abolish, Ub binding. However, a higher-affinity complex that depends on specific contacts between Phe 495 and Ub has an essential role in priming the thioester bond for catalysis.
DISCUSSION
Ubiquitylation of many proteins depends on the ability of a RING domain of the E3 ligase to destabilize a thioester bond between the E2 and the Ub moieties of an E2∼Ub conjugate. The molecular details that underpin RING domain-enhanced ubiquitylation are only just emerging. In the present study, we show that RING dimerization, as well as specific contacts between the RING domain and Ub, are required for XIAP-mediated Ub transfer. Using a cross-linking strategy, likely to be broadly applicable for the identification of other Ub-binding sites, we identified the Ub-binding site on the XIAP RING. We also show that the RING domain of XIAP forms a stable dimer. In contrast with the cIAPs [14, 15] , the UBA and BIR3 domains of XIAP do not inhibit RING dimerization. As a consequence, an activation step is not required, and in the present study XIAP can directly engage the E2∼Ub conjugate. In addition, compounds that activate Ub transfer by other IAPs, notably cIAP1 and cIAP2 [14, 18] , do not enhance the Ub transfer of X-BUR.
The structure of the RING domain dimer from XIAP resembles the cIAP2 and ML-IAP RING dimers [3, 12] . In all three structures, the conserved C-terminal residues, which extend beyond the core RING domain, make contacts at the dimer interface ( Figure 2D and Supplementary Figure S2A) . These residues have an essential role in Ub transfer, and their mutation or deletion disrupts RING dimerization and activity. Notably, mutation of the conserved phenylalanine residue to alanine abrogates activity and is frequently used to generate inactive IAP proteins [14, 23, 32] . For the cIAP proteins, mutation of the aromatic residue (F602A in cIAP2 and F616A in cIAP1) disrupts dimer formation [3, 14] and this is thought to underpin inactivation of these proteins. However, the equivalent mutation in XIAP does not destabilize the dimer, nor prevent E2∼Ub binding, but instead abolishes its ability to effectively catalyse Ub transfer. As the oligomeric state of inactive cIAP1, cIAP2 and XIAP variants possessing the alanine residue substitution differs, interpretation of these mutants in a cellular setting may be complicated as the oligomeric state of the mutant protein may independently influence localization and activity of the protein.
In the two available structures of RING domain dimers bound to an E2∼Ub conjugate, similar interactions are made between the RING domain and the E2∼Ub conjugate, and contacts involve 400-500 Å 2 on both E2 and ubiquitin [11, 12] . Of particular interest, the aromatic residue (Tyr 193 of RNF4 and Phe 296 of ML-IAP) packs against Gly 35 at the C-terminal end of the α-helix in Ub ( Figure 6A) . The contacts involve a relatively strong hydrogen bond (2.9 Å) between the Nε2 of the zinc-co-ordinating histidine residue (His 160 of RNF4 and His 269 of ML-IAP) and the main chain carbonyl of Glu 34 in Ub, as well as CH-π stacking between the phenylalanine aryl group of the RING domain and the Cα hydrogen of Gly 35 (distance between the carbon atom and the centre of mass of the aromatic ring is 3.7 Å) [33] . Consistent with the importance of this interaction, activity was retained when other aromatic residues substituted the phenylalanine in XIAP, however, substitution with leucine abolished Ub transfer ( Figure 6B ). Given that the binding and cross-linking data indicated that Ub still contacted the C-terminal tail residues of the inactive F495L mutant, it seems likely that the CH-π stacking interaction is required for tight binding of the conjugate so that nucleophilic attack is favoured.
The essential aromatic residue is conserved and occupies a similar position (10-11 residues from the last zinc-co-ordinating residue) in the RING dimers from IDOL (inducible degrader of the low-density-lipoprotein receptor) [5] , MDM (murine double minute) 2 and MDMX [34] (Supplementary Figure S1B) , suggesting similar interactions will contribute to Ub binding. Functionally, the importance of the C-terminal residues has been most thoroughly studied for MDM2 and MDMX. MDM2 is a RING-dependent E3 enzyme and both the MDM2 homodimer and the MDM2-MDMX heterodimer are active E3 ligases, whereas MDMX RING homodimers are inactive [34] [35] [36] . Consistent with current models of E2∼Ub conjugate recruitment, the MDM2-MDMX heterodimer retains activity when the C-terminal tail of MDM2 is mutated, yet mutation of the MDMX tail disrupts activity. Surprisingly, a point mutation at the MDMX dimer interface, which replaces Asn 448 with a cysteine residue (N448C), converts homodimeric MDMX into an active E3 ligase [37] and this activity is further enhanced by the additional mutation I450V. Although the structural basis for this increased activity is unknown, the present study suggests that these mutations (N448C and I450V) might modify the RING dimer structure, such that the critical aromatic residue in the tail can make a productive contact with Ub of the E2∼Ub conjugate.
The two available structures of RING domains in complex with the E2∼Ub conjugate suggest conserved interactions are responsible for the interaction of Ub with the RING domain [11, 12] . However, the structurally equivalent residues are not conserved for other dimeric E3 ligases, such as Ring1b (RNF2)-Bmi1 (BMI1 polycomb ring finger oncogene) [4] , RNF8 [38] , Rad18 [39] , BRCA1 (breast cancer susceptibility gene 1)-BARD1 (BRCA1-associated RING domain 1) [40] and PRP19 (pre-mRNA-processing factor 19) [41] and although the binding surface might be conserved, the contacts with Ub will differ. It is also probable that some E3 ligases will utilize structurally distinct residues to ensure that the E2∼Ub is preferentially bound. The importance of other motifs is emphasized by the structure of the RanBP2 (RAN-binding protein 2)-SUMO (small Ub-related modifier)-RanGAP1 (Ran GTPase-activating protein 1)-Ubc9 (Ub-conjugating enzyme 9) complex [42] . In this structure, a SIM (SUMO-interacting motif) domain in RanBP2 binds to SUMO and locks it in position so that the E2 (Ubc9)-SUMO conjugate adopts a closed conformation, with the C-terminal residues of SUMO positioned in the catalytic site of Ubc9 in the same way as the Ub tail is positioned in the RNF4-UBE2D2∼Ub complex [11] . This type of interaction may also be important for the monomeric RING E3 ligases, such as Rbx1 (ring-box 1, E3 Ub protein ligase) and E4B, that retain the ability to selectively recruit the conjugate [10] and interact with Ub [9] . Whatever the nature of the RING-Ub interaction, our analysis of XIAP indicates that binding alone is not sufficient for Ub transfer. Instead specific contacts are required to ensure that the C-terminal residues of Ub are extended and the thioester bond is susceptible to nucleophilic attack.
For XIAP, RING dimerization is not only required for interaction with the E2∼Ub conjugate, but is also required for E2 binding. In the cIAP2 RING-E2 complex, interaction with E2 largely depends on the core RING domain, but there are additional contacts between E2 and the N-terminal helix (residues 549-556) [3] . In the structure of the autoinhibited cIAP1 monomer the N-terminal helix folds back against the core of the RING, owing to flexibility of the kink, and this interaction is expected to restrict interaction with the E2 (Supplementary Figure S1B ) [15] . It is possible that a similar interaction prevents interaction of monomeric forms of XIAP (V461E) with E2. However, it is less clear that an autoinhibited monomer is physiologically relevant since both the X-RING and X-BUR proteins form stable dimers. In addition, the BIR1 domains of XIAP also dimerize and their interaction has been reported to be important for XIAP function [43] . Regulation of XIAP E3 ligase activity may be achieved in other ways. For example, XAF1 (XIAP associated factor 1) is reported to bind the canonical E2-binding interface on the XIAP RING [44] and this could mask E2 binding in a similar manner to that reported for Rbx1 [45] . Phosphorylation at Ser 430 has also been reported to modulate XIAP, because mutation to an aspartic acid residue (S430D) resulted in rapid degradation of XIAP, whereas mutation to an alanine (S430A) stabilized XIAP [46] .
XIAP is highly expressed in many tumour cell lines and patient tumour samples, and high levels of XIAP are thought to confer resistance to anti-cancer therapies by binding to and inhibiting caspase function [47] . In addition, the clinically relevant SMAC mimetic compounds designed to displace caspases from XIAP also bind cIAP1/2 and promote their dimerization, autoubiquitylation and degradation [48] . The ability of SMAC mimetics to promote the loss of cIAP1 and cIAP2 dysregulates death receptor signalling and triggers apoptosis, and is now recognized as their primary function [17] . However, the effect of SMAC mimetics on XIAP function remains a critical consideration because, in addition to caspase repression, XIAP regulates NOD signalling via E3-mediated ubiquitylation of RIPK2 that is thought to bind to the BIR2 of XIAP [23, 49] . As a consequence, the addition of compounds that alter XIAP E3 ligase activity and abundance may alter NOD-mediated inflammatory signalling. Many monovalent and bivalent SMAC mimetics can bind both XIAP and cIAP1/2, therefore a detailed understanding of XIAP-dependent Ub transfer is required. The present study provides critical insights into the E3 ligase enzyme activity of XIAP and contributes to a greater understanding of XIAP antagonism as it relates to cancer therapeutics and receptor signalling. 
